background
mutat
subunit
rnadepend
rna
polymeras
rdrp
influenza
viru
affect
replic
fidel
influenza
pandem
human
influenza
virus
contain
avianassoci
residu
serin
posit
howev
near
onset
pandem
human
virus
began
acquir
mammalianassoci
residu
glycin
becam
predomin
human
virus
thereaft
method
use
entropybas
analysi
algorithm
previous
identifi
sever
hostspecif
aminoacid
signatur
separ
avian
swine
virus
human
influenza
virus
presenc
hostspecif
signatur
human
influenza
virus
suggest
mutat
result
adapt
genet
evolut
enabl
influenza
virus
circumv
host
barrier
result
crossspeci
transmiss
investig
biolog
impact
natur
aviantomammalian
signatur
substitut
human
influenza
virus
result
found
virus
greater
mutat
potenti
sensit
ribavirin
virus
oseltamivirtr
cell
virus
gener
mutat
viral
neuraminidas
higher
rate
virus
contrast
virus
virul
mice
virus
result
suggest
substitut
enhanc
viral
epidemiolog
fit
increas
frequenc
adapt
mutat
human
influenza
virus
result
thu
suggest
increas
adapt
epidemiolog
fit
natur
aris
human
virus
canon
lowfidel
replicas
biolog
mechan
underli
replac
virus
highfidel
replicas
follow
emerg
think
continu
surveil
natur
occur
variant
among
other
warrant
assess
potenti
impact
chang
rdrp
fidel
adapt
epidemiolog
fit
human
influenza
virus
genom
influenza
virus
famili
orthomyxovirida
contain
eight
segment
singlestrand
negativesens
rna
antigen
shift
result
reassort
genom
segment
differ
strain
influenza
virus
often
differ
host
speci
uniqu
antigen
newli
emerg
reassort
strain
evad
exist
herd
immun
circul
season
influenza
virus
type
punctuat
antigen
variat
contribut
influenza
pandem
throughout
histori
pandem
influenza
strain
becom
preval
influenza
viru
popul
contribut
uniqu
genet
characterist
gene
pool
subsequ
season
influenza
virus
sinc
emerg
earli
swineorigin
pandem
influenza
viru
becom
circul
season
human
influenza
viru
despit
tempor
associ
swine
genom
contain
multipl
reassort
viral
gene
deriv
avian
influenza
virus
pa
genom
segment
origin
avian
influenza
viru
previous
reassort
swine
influenza
viru
genom
segment
recent
acquir
human
season
influenza
viru
previous
acquir
avian
influenza
viru
hemagglutinin
ha
nucleoprotein
np
nonstructur
ns
genom
segment
north
american
swine
influenza
viru
lineag
trace
pandem
viru
neuraminidas
na
matrix
genom
segment
eurasian
swine
viru
previous
acquir
segment
avian
influenza
viru
overal
influenc
emerg
gene
pool
current
circul
season
human
influenza
virus
remain
larg
unclear
like
rna
virus
rnadepend
rna
polymeras
rdrp
influenza
virus
higher
error
rate
dna
polymeras
lack
proofread
mechan
nucleotid
misincorpor
rdrp
replic
contribut
antigen
drift
increas
probabl
viru
evad
host
immun
season
influenza
virus
accord
quasispeci
theori
inher
infidel
rdrp
drive
format
variant
cloud
influenza
viru
popul
consist
divers
genet
variant
link
share
mutat
variant
collect
contribut
antigen
characterist
influenza
viru
popul
interact
cooper
function
level
select
pressur
act
upon
popul
whole
mutant
cloud
provid
dynam
repositori
variant
permit
certain
virus
undergo
adapt
select
pressur
includ
speci
barrier
host
immun
respons
antivir
agent
increas
mutat
rate
allow
rna
virus
opportun
adjust
environment
stress
wherea
elev
rna
replicas
fidel
despit
allow
viru
stabli
pass
genet
trait
progeni
actual
serv
restrict
genet
divers
among
virus
occupi
greatest
space
fit
landscap
fidel
determin
rdrp
first
describ
polioviru
chikungunya
viru
singlestrand
positivesens
rna
virus
variant
virus
exhibit
certain
degre
attenu
fit
loss
vivo
like
result
restrict
genet
divers
cost
increas
fidel
sitedirect
mutagenesi
predict
key
residu
rdrp
coxsacki
viru
exoribonucleas
coronaviru
produc
variant
mutat
phenotyp
less
virul
vivo
wildtyp
parent
virus
alter
fidel
rdrp
clearli
affect
virul
fit
rna
virus
vivo
demonstr
critic
role
rdrp
play
balanc
pathogenesi
adapt
largescal
entropybas
comput
algorithm
influenza
viru
sequenc
deposit
influenza
viru
databas
http
wwwncbinlmnihgovgenom
flu
databasenphselectcgi
go
databas
primarili
standard
prevalencefrequ
analysi
previous
character
avianand
humanspecif
genom
signatur
show
avian
virus
contain
serin
valin
wherea
sequenc
contain
glycin
isoleucin
thu
consid
host
speciesassoci
amino
acid
posit
influenza
virus
humanassoci
residu
wherea
associ
infect
swine
human
time
biolog
signific
antigen
variat
enabl
virus
switch
host
speci
poorli
understood
sinc
becom
circul
season
human
influenza
viru
worldwid
current
studi
investig
impact
gene
pool
current
circul
season
influenza
virus
found
serinetoglycin
point
mutat
nucleotid
posit
significantli
reduc
rdrp
fidel
virus
demonstr
increas
sensit
ribavirin
reduc
virul
mice
cell
treat
naspecif
inhibitor
oseltamivir
virus
gener
mutat
na
faster
rate
virus
find
highlight
need
continu
monitor
identifi
emerg
adapt
mutat
might
contribut
futur
influenza
pandem
madindarbi
canin
kidney
mdck
atcc
cell
human
embryon
kidney
atcc
hek
atcc
cell
grown
complet
dulbecco
modifi
eagl
mediumhigh
glucos
dmemhg
supplement
fetal
bovin
serum
recombin
virus
gener
vitro
use
revers
genet
method
previous
describ
cell
transfect
use
polyjet
dna
transfect
reagent
signagen
rockvil
md
usa
cell
cotransfect
eight
plasmid
mgplasmid
contain
one
eight
genom
segment
influenza
viru
viral
gene
express
control
dual
promot
inoculum
remov
h
posttransfect
replac
serum
free
dmemhg
medium
contain
trypsin
life
technolog
carlsbad
ca
usa
h
posttransfect
cultur
supernat
collect
viru
recoveri
recombin
virus
amplifi
mdck
cell
passag
viru
titer
determin
plaqu
assay
singlenucleotid
mutat
introduc
plasmid
sitedirect
mutagenesi
previous
describ
fulllength
sequenc
eight
viral
genom
segment
obtain
convent
dna
sequenc
recombin
viru
contain
eight
viral
genom
segment
viru
contain
eight
viral
genom
segment
residu
replac
serin
glycin
residu
replac
isoleucin
arginin
recombin
viru
contain
seven
viral
genom
segment
segment
recombin
viru
differ
recombin
viru
residu
replac
glycin
serin
viru
growth
curv
assay
mdck
cell
seed
cellswel
plate
h
infect
mdck
cell
wash
ml
pb
twice
follow
infect
virus
moi
incub
h
cell
wash
twice
ml
pb
follow
ad
ml
dmemhg
medium
well
contain
mgml
tpcktreat
trypsin
incub
supernat
collect
indic
hour
postinfect
viral
titer
determin
plaqu
assay
mdck
cell
seed
cellswel
plate
viru
infect
h
viru
titer
evalu
serial
dilut
plate
h
postinfect
cell
wash
twice
ml
pb
cell
overlaid
ml
dmem
hg
medium
supplement
agaros
incub
h
cell
fix
formalin
least
h
crystal
violet
stain
viru
titer
calcul
number
plaqu
form
unit
pfu
per
millilit
anim
experi
approv
institut
anim
care
use
committe
nation
defens
medic
center
femal
balbc
mice
week
age
purchas
nation
laboratori
anim
center
taipei
taiwan
hous
specif
pathogenfre
condit
viru
challeng
week
age
four
seven
mice
per
group
anesthet
intraperiton
inject
mg
zolazepam
chlorhydr
virbac
carro
franc
intranas
inocul
viru
solut
contain
pfu
serum
free
dmemhg
control
mice
observ
ill
death
day
ill
record
lethal
mice
lost
bodi
weight
euthan
perform
human
co
asphyxi
lung
titer
determin
three
five
mice
per
group
euthan
h
postinfect
lung
homogen
ml
dmemhg
supplement
antibiot
tpcktreat
trypsin
homogen
centrifug
min
supernat
aliquot
store
viral
titrat
lung
viral
titer
determin
plaqu
assay
describ
previous
cell
cellswel
cell
transfect
ng
plate
use
lipofectamin
invitrogen
carlsbad
ca
usa
total
volum
accord
manufactur
protocol
transfect
medium
remov
h
later
replac
fresh
medium
h
posttransfect
cell
viru
infect
moi
h
postinfect
cell
lyse
firefli
luciferas
fluc
renilla
luciferas
rluc
activ
measur
viral
replic
measur
base
rluc
activ
mutat
potenti
calcul
cumul
mutat
index
cmi
wherebi
cmi
flucrluc
detail
descript
pleas
refer
addit
file
figur
replic
capabl
cumul
mutat
index
cmi
dualluciferas
report
briefli
influenza
viru
rdrp
minireplicon
hek
cell
seed
plate
h
transfect
use
polyjet
dna
transfect
reagent
signagen
rockvil
md
accord
manufactur
protocol
wwwsignagencom
two
hundr
nanogram
express
plasmid
encod
pa
np
wildtyp
variant
cotransfect
ng
report
fig
h
post
transfect
cell
lyse
firefli
flu
renilla
rlu
luciferas
activ
measur
use
dualglo
luciferas
assay
system
promega
accord
manufactur
protocol
replic
capabl
rdrp
rel
rlu
luciferas
activ
mutat
potenti
cmi
flucrluc
ratio
calcul
cell
transfect
report
describ
h
posttransfect
cell
treat
ribavirin
h
viral
infect
h
postinfect
cell
lyse
fluc
rluc
luciferas
activ
measur
protein
sequenc
avian
swine
human
fig
fig
determin
genom
sequenc
genom
segment
data
human
virus
download
genbank
march
whole
viral
genom
analysi
variou
genom
first
divid
two
group
base
whether
residu
g
na
segment
group
align
identifi
na
mutat
oseltamivirresist
variant
tabl
wildtyp
virus
passag
twice
mdck
cell
moi
viral
supernat
viral
rna
subject
revers
transcript
use
superscript
iii
revers
transcriptas
life
technolog
univers
primer
ha
cdna
amplifi
phusion
highfidel
dna
polymeras
thermo
scientif
forward
revers
primer
pcr
product
clone
use
clonejet
pcr
clone
kit
thermo
scientif
accord
manufactur
protocol
clone
sequenc
abi
prism
sequenc
analyz
appli
biosystem
cell
infect
moi
h
cell
serial
passag
increment
increas
concentr
oseltamivir
toronto
research
chemic
concentr
oseltamivir
nm
approxim
nm
ad
gradual
nm
maintain
passag
thereaft
passag
describ
addit
file
figur
cultur
supernat
collect
h
passag
previous
describ
convent
sanger
sequenc
analysi
viral
rna
purifi
revers
transcript
describ
cdna
amplifi
pcr
use
naspecif
primer
set
primer
set
b
respect
pcr
product
subject
direct
sanger
sequenc
deep
sequenc
analysi
nucleotid
na
correspond
amino
acid
sequenc
genom
ltd
taiwan
illumina
miseq
platform
cdna
pcr
amplifi
use
follow
barcod
primer
gatgtcaccgaaaa
total
read
obtain
million
per
strain
output
data
gb
target
mean
qualiti
score
output
data
first
sort
barcod
sequenc
repres
na
plasmid
na
na
given
gener
error
rate
invitrogen
superscript
iii
revers
transcriptas
use
studi
arbitrarili
defin
cutoff
valu
mutat
million
read
therefor
posit
mutat
occur
frequenc
higher
consid
significantli
variabl
amino
acid
posit
influenza
speciesassoci
posit
distinguish
human
avian
influenza
virus
emerg
entropybas
comput
approach
character
avianhuman
signatur
previous
identifi
sever
humanassoci
posit
pandem
viru
genom
within
intern
gene
rdrp
complex
fact
pandem
viru
strain
subsequ
becom
human
season
influenza
strain
current
circul
worldwid
interest
monitor
characterist
chang
amino
acid
may
attribut
emerg
pandem
viru
current
offspr
human
season
previou
studi
one
speciesassoci
posit
identifi
exclus
humanlik
residu
gli
found
pandem
virus
yet
pandem
episod
human
influenza
deposit
avian
signatur
ser
coexist
avian
influenza
virus
contrast
regardless
pandem
impact
observ
pandem
viru
still
remain
humanlik
residu
ile
avian
influenza
almost
avianassoci
val
observ
impli
may
major
transit
pattern
avian
human
occur
amongst
differ
influenza
viru
popul
pandem
outbreak
understand
signific
point
mutat
first
investig
chronolog
chang
nucleotid
posit
virus
collect
differ
host
avian
swine
human
deposit
influenza
viru
databas
found
avian
virus
contain
v
fig
human
virus
also
contain
avianassoci
residu
serin
howev
emerg
human
virus
primarili
like
via
genom
reassort
thereaft
remain
preval
residu
glycin
posit
contrast
human
virus
contain
mammalianassoci
residu
isoleucin
swine
virus
exhibit
frequent
substitut
avianand
mammalianassoci
residu
reflect
suscept
swine
avian
human
influenza
virus
human
hand
also
infect
swine
influenza
virus
virus
substitut
avian
mammalian
signatur
readili
observ
collect
avian
swine
virus
fig
essenti
none
human
virus
exhibit
chang
emerg
inde
preval
among
human
virus
long
given
genom
segment
viru
recent
acquir
human
season
viru
examin
sequenc
deposit
determin
whether
avian
mammalian
substitut
previous
occur
human
virus
found
point
mutat
inde
occur
remain
preval
signatur
human
virus
addit
file
figur
observ
suggest
substitut
avianassoci
residu
serin
humanassoci
residu
glycin
onset
pandem
result
robust
evolutionari
adapt
impact
current
circul
season
human
virus
worldwid
viru
clinic
isol
taiwan
contain
report
less
virul
mice
compar
apuerto
viru
widelyus
influenza
laboratori
refer
strain
contain
contain
typic
human
signatur
gli
ile
contrast
laboratori
refer
strain
exhibit
avian
signatur
correspond
posit
examin
whether
differ
pathogen
mice
associ
avian
mammalian
signatur
sequenc
first
use
revers
genet
recov
reassort
viru
contain
whole
genom
segment
also
gener
variant
point
mutat
evalu
effect
mutat
compar
replic
virul
parent
madindarbi
canin
kidney
mdck
cell
intranas
inocul
balbc
mice
growth
curv
mdck
cell
similar
p
fig
mice
infect
caus
significantli
higher
lungtissu
viru
titer
p
lower
surviv
p
compar
fig
c
exhibit
significantli
higher
surviv
p
p
investig
role
virul
mice
use
viru
gener
variant
use
variant
control
experi
mutat
expect
affect
polymeras
activ
fidel
growth
curv
mdck
cell
similar
p
fig
mice
infect
lungtissu
viru
titer
surviv
similar
mice
p
fig
c
mice
infect
significantli
lower
lungtissu
viru
titer
p
exhibit
improv
surviv
p
compar
mice
result
indic
avianassoci
major
virul
determin
influenza
virus
mice
lethal
challeng
test
mice
biolog
signific
could
readili
observ
differ
contain
virus
fig
influenza
virus
appear
virul
viru
virus
contribut
higher
mutat
frequenc
compar
replic
level
viral
rna
report
gene
use
quantifi
replic
mutat
frequenc
hiv
revers
transcriptas
rdrp
cucumb
mosaic
viru
rdrp
fidel
associ
virul
influenza
virus
mice
investig
whether
point
mutat
affect
mutat
frequenc
construct
artifici
influenza
genom
segment
contain
dual
luciferas
rna
report
gene
contain
open
read
frame
firefli
renilla
luciferas
connect
tandem
uaa
stop
codon
fig
replic
capabl
determin
base
renilla
luciferas
rluc
activ
ratio
activ
firefli
luciferas
fluc
rluc
use
quantifi
rdrp
fidel
base
frequenc
stop
codon
repair
viral
replic
transcript
express
cumul
mutat
index
cmi
wherebi
cmi
fluc
rluc
addit
file
figur
influenzavirusinfect
cell
transfect
found
viru
replic
level
similar
fig
variant
exhibit
significantli
higher
cmi
compar
p
p
respect
fig
addit
combin
express
construct
polymeras
subunit
pa
np
protein
dualluciferas
report
replicon
system
allow
quickli
measur
replic
capabl
evalu
mutat
potenti
given
influenza
rdrp
activ
use
variou
variant
use
minireplicon
assay
system
fig
e
compar
replic
capabl
mutat
potenti
pair
pa
np
pa
np
pa
np
pa
np
well
pa
np
pa
np
respect
replic
capabl
rdrp
measur
rluc
activ
significantli
differ
fig
indic
swap
gli
ser
affect
rdrp
replic
level
howev
mutat
potenti
rdrp
determin
cmi
fig
show
rdrp
complex
deriv
differ
virus
could
exhibit
significantli
higher
mutat
capabl
especi
experiment
group
pa
np
pa
np
four
polymeras
subunit
pa
np
protein
could
close
interact
viral
replic
nativ
background
viru
clinic
isol
taiwan
studi
result
fig
confirm
use
previous
describ
convent
assay
determin
rdrp
nucleotid
incorpor
fidel
clonal
sequenc
compar
frequenc
mutat
ha
result
shown
tabl
mutat
frequenc
significantli
greater
p
combin
result
experi
indic
mammalian
signatur
influenza
virus
confer
lower
rdrp
fidel
avian
signatur
therebi
increas
frequenc
mutat
viral
replic
ribavirin
nucleotid
analog
target
rdrp
caus
lethal
hypermut
rna
virus
previou
studi
mutant
variant
polioviru
ttest
ab
c
group
femal
balbc
mice
week
age
challeng
infect
surviv
rate
infect
mice
record
daili
day
logrank
mantelcox
test
use
confirm
statist
signific
differ
surviv
rate
p
p
p
p
exhibit
enhanc
rdrp
fidel
resist
ribavirin
treatment
wildtyp
polioviru
low
rdrp
fidel
like
faith
rdrp
gener
less
mutat
viral
replic
similar
observ
also
report
hiv
studi
high
fidel
revers
transcriptas
could
reduc
lethal
toxic
nucleosid
analogu
make
less
mutat
retrovir
replic
studi
examin
effect
point
mutat
resist
ribavirin
treatment
compar
replic
virus
cell
presenc
variou
concentr
ribavirin
found
ribavirinmedi
inhibit
replic
significantli
greater
especi
ribavirin
fig
result
indic
point
mutat
influenza
viru
could
reduc
rdrp
fidel
also
increas
sensit
ribavirin
replic
consist
result
previou
report
concern
polioviru
hiv
consider
discuss
concern
low
replic
fidel
rna
virus
might
contribut
adapt
evolut
enhanc
viral
fit
infect
host
increas
genet
divers
viru
popul
previou
studi
chikungunya
viru
variant
found
increas
rdrp
fidel
result
reduc
genet
divers
lower
fig
effect
mutat
replic
capabl
mutat
potenti
virusinfect
cell
use
dualluciferas
report
schemat
diagram
mutabl
assay
influenza
rdrp
dualluciferas
report
flank
utr
sequenc
wsnnp
genom
transcript
control
human
poli
promot
murin
termin
b
replic
capabl
calcul
base
rluc
luciferas
activ
c
mutat
potenti
calcul
cumul
mutat
index
cmi
base
fluc
rluc
ratio
e
mutat
potenti
rdrp
variant
measur
influenza
minireplicon
system
pa
np
express
plasmid
plu
wildtyp
variant
plasmid
cotransfect
report
hek
cell
h
replic
capabl
rlu
luciferas
activ
mutat
potenti
cumul
mutat
index
cmi
e
flucrluc
ratio
evalu
indic
plasmid
contain
either
respect
error
bar
indic
standard
error
mean
three
independ
experi
student
twotail
unpair
ttest
perform
determin
p
valu
ns
signific
p
fit
natur
mosquito
host
newborn
mice
compar
wildtyp
chikungunya
viru
previou
studi
polioviru
variant
increas
fidel
result
less
diversifi
popul
reduc
adapt
advers
growth
condit
mutat
influenza
associ
highfidel
rdrp
analysi
influenza
viru
sequenc
show
appear
human
influenza
virus
occur
rare
avian
swine
swine
virus
addit
file
figur
therebi
exclud
factor
displac
virus
virus
viral
neuraminidas
inhibitor
nai
oseltamivir
mutagen
per
se
contribut
emerg
nairesist
mutat
within
na
gene
result
random
rdrpmediat
nucleotid
misincorpor
viral
replic
naitreat
cell
previou
studi
influenza
report
na
mutat
includ
contribut
oseltamivir
resist
gain
insight
lowfidel
variant
replac
emerg
examin
incid
mutat
confer
oseltamivir
resist
found
incid
oseltamivir
resist
much
lower
point
mutat
coincid
steep
rise
incid
oseltamivir
resist
mutat
worldwid
addit
file
tabl
oseltamivirsensit
viru
emerg
fig
number
oseltamivirresist
virus
decreas
rapidli
thu
rapid
displac
coincid
displac
avian
signatur
mammalian
signatur
field
data
addit
file
tabl
also
show
five
distinctli
differ
na
mutat
confer
oseltamivir
resist
n
occur
pandem
pattern
oseltamivir
resist
confirm
whole
genom
analysi
show
virus
oseltamivir
sensit
oseltamivir
resist
virus
contain
least
one
five
na
mutat
tabl
examin
incid
permiss
secondari
mutat
shown
improv
fit
virus
incid
k
decreas
first
half
howev
number
virus
increas
rel
replic
capabl
determin
rlucrluc
without
ribavirin
ratio
error
bar
standard
error
mean
three
independ
experi
ns
signific
p
student
twotail
unpair
ttest
p
p
wildtyp
virus
passag
twice
mdck
cell
ha
cdna
amplifi
viral
supernat
clone
describ
method
ha
mutat
frequenc
determin
clonal
sequenc
bacteri
clone
experi
pick
repeat
independ
three
time
student
twotail
unpair
ttest
ns
signific
becam
predomin
addit
file
tabl
investig
whether
rdrp
fidel
affect
influenza
viru
adapt
stress
use
modifi
version
previous
describ
method
vitro
select
oseltamivirresist
variant
assess
effect
point
mutat
frequenc
mutat
na
confer
oseltamivir
resist
shown
addit
file
figur
infect
mdck
cell
serial
passag
success
incub
progress
higher
concentr
oseltamivir
reach
maximum
concentr
nm
oseltamivir
passag
thereaft
na
gene
sequenc
determin
passag
convent
sanger
sequenc
viral
cdna
allow
identif
mutat
singl
rel
long
read
without
assembl
annot
shotgun
sequenc
data
obtain
use
highthroughput
method
na
mutat
first
detect
passag
serin
preval
residu
passag
thereaft
addit
file
figur
right
mutat
detect
na
gene
na
mutat
first
detect
passag
tyrosin
becam
preval
residu
passag
addit
file
figur
left
result
illustr
virus
could
acquir
adapt
mutat
na
confer
oseltamivir
resist
higher
frequenc
virus
virus
nevertheless
remain
unclear
two
differ
na
mutat
could
independ
emerg
select
pressur
given
viru
strain
use
abovement
experi
synchron
passag
investig
whether
na
na
mere
preexist
mutant
popul
respect
follow
revers
genet
recoveri
nucleotid
amino
acid
posit
na
gene
passag
subject
deep
sequenc
region
select
includ
posit
previous
identifi
na
mutat
confer
oseltamivir
resist
sanger
sequenc
previou
studi
shown
major
mutat
confer
nai
resist
influenza
virus
occur
region
na
gene
analysi
show
passag
total
mutat
occur
respect
among
share
two
virus
fig
remain
mutat
n
n
uniqu
viru
fig
addit
passag
oseltamivirresist
mutat
na
na
could
detect
either
ng
analysi
strongli
suggest
adapt
mutat
confer
nai
resist
cellbas
select
system
observ
addit
file
figur
b
moreov
result
show
gener
compar
level
popul
divers
absenc
substanti
select
pressur
evidenc
similarli
larg
number
mutat
present
viru
passag
fig
although
human
virus
avianassoci
substitut
mammalianassoci
occur
near
end
period
becam
predomin
human
virus
thereaft
addit
file
figur
viru
contain
mammalian
signatur
reassort
origin
result
emerg
fig
studi
investig
biolog
signific
point
mutat
human
virus
tabl
whole
genom
analysi
correl
na
mutat
confer
oseltamivir
resist
human
influenza
virus
genom
set
retriev
influenza
viru
databas
genbank
na
sequenc
virus
blue
virus
red
align
analyz
identifi
na
mutat
confer
oseltamivir
resist
permiss
secondari
mutat
na
virul
mice
shown
less
refer
strain
contain
avian
signatur
found
virul
mice
reassort
viru
contain
mammalian
signatur
despit
share
homolog
fig
produc
avian
signatur
viru
appear
restor
virul
level
similar
fig
produc
mammalian
signatur
viru
hand
reduc
virul
compar
fig
result
clearli
demonstr
import
virul
determin
influenza
virus
mice
use
ribavirin
select
resist
virus
molecular
basi
fidel
determin
within
rdrp
gene
identifi
rna
virus
includ
polioviru
chikungunya
viru
influenza
virus
ribavirinresist
virus
typic
contain
mutat
within
rdrp
gene
caus
elevatedfidel
phenotyp
exhibit
lower
fit
andor
lower
virul
infect
anim
compar
parent
virus
among
highfidel
rdrp
mutat
ribavirinresist
variant
variant
influenza
exhibit
reduc
viru
popul
divers
attenu
virul
low
neurotrop
mice
contrast
mutat
key
residu
rdrp
coxsackieviru
exoribonucleas
coronavirus
gener
viru
variant
exhibit
elev
mutat
frequenc
attenu
virul
mice
previous
identifi
sever
hostspecif
aminoacid
signatur
separ
avian
swine
virus
human
influenza
virus
via
entropybas
algorithm
analysi
influenza
sequenc
deposit
genbank
presenc
hostspecif
signatur
human
influenza
virus
suggest
mutat
result
adapt
genet
evolut
enabl
influenza
virus
circumv
host
barrier
like
result
crossspeci
transmiss
data
show
aviantomammalian
signatur
substitut
serinetoglycin
highli
suggest
avianswin
human
influenza
viru
transmiss
contribut
influenza
outbreak
caus
howev
mechan
hostsignatur
substitut
ultim
affect
virul
fit
remain
unclear
worth
investig
chang
structur
viral
polymeras
complex
serin
glycin
influenza
finetun
rdrp
fidel
viru
replic
result
current
studi
show
natur
switch
serin
glycin
increas
mutat
frequenc
reduc
fidel
rdrp
fig
tabl
virus
sensit
ribavirin
inhibit
fig
acquir
oseltamivirresist
mutat
vitro
faster
rate
cellbas
select
system
although
mutat
potenti
greater
result
reduc
rdrp
fidel
variant
similar
level
genet
divers
observ
popul
viru
fig
observ
contrast
sharpli
reduc
genet
divers
report
virus
highfidel
rdrp
mutat
addit
virul
lowfidel
viru
mice
attenu
rel
parent
viru
fig
inconsist
attenu
phenotyp
previous
report
highfidel
influenza
variant
obtain
ribavirin
select
howev
observ
consist
previous
report
concern
certain
virus
lower
fidel
inde
display
attenu
properti
vivo
determin
differ
mutat
frequenc
approxim
convent
sequenc
tabl
approxim
minireplicon
report
assay
fig
although
differ
mutat
frequenc
rel
small
effect
point
mutat
replic
adapt
compar
readili
appar
result
ribavirin
inhibit
assay
fig
vitro
nai
assay
addit
file
figur
observ
indic
influenza
virus
may
differ
subtli
rdrp
fidel
gener
varieti
variant
clinic
relev
condit
exhibit
similar
infect
growth
characterist
gener
compar
level
popul
divers
sinc
pandem
outbreak
human
influenza
virus
becom
widespread
worldwid
major
season
influenza
virus
current
cocircul
influenza
influenza
b
virus
contrast
current
exclus
predomin
human
virus
analysi
influenza
viru
sequenc
deposit
genbank
fig
addit
file
figur
show
remain
predomin
avian
influenza
virus
also
found
mutat
associ
highfidel
rdrp
occur
rare
avian
swine
well
swine
virus
found
human
influenza
virus
result
indic
although
highfidel
influenza
variant
obtain
revers
genet
occur
sporad
field
confer
signific
evolutionari
advantag
rel
v
virus
focus
investig
identifi
biolog
mechan
lowfidel
variant
replac
human
influenza
virus
exist
prior
influenza
pandem
found
incid
oseltamivir
resist
human
influenza
virus
much
lower
time
emerg
oseltamivir
resist
variant
rose
steepli
worldwid
due
point
mutat
frequenc
peak
first
quarter
nearli
na
deposit
contain
mutat
addit
file
tabl
howev
oseltamivirsensit
viru
emerg
contain
rapidli
displac
oseltamivirresist
virus
afterward
proport
oseltamivirresist
virus
avianassoci
increas
rapidli
predomin
human
influenza
popul
first
half
subsequ
replac
oseltamivirsensit
equal
rapid
rate
addit
file
tabl
nonetheless
chang
oseltamivir
sensit
popul
level
coincid
close
rise
preval
mammalianassoci
lowfidel
influenza
virus
near
onset
influenza
pandem
fig
tabl
one
appeal
hypothesi
higherfidel
rdrp
oseltamivirresist
virus
result
higher
replic
rate
absenc
oseltamivir
select
pressur
therebi
rapidli
increas
proport
virus
popul
swine
influenza
pandem
first
quarter
rapid
rise
predomin
follow
develop
certain
unidentifi
environment
bottleneck
plu
acquisit
lowfidel
viru
remain
continu
present
popul
allow
undergo
adapt
mutat
higher
rate
higherfidel
oseltamivirresist
virus
therebi
contribut
extinct
virus
follow
pandem
data
addit
file
tabl
show
prior
midpoint
oseltamivir
resist
associ
almost
exclus
virus
wherea
five
addit
distinctli
differ
na
mutat
n
also
associ
oseltamivir
resist
follow
pandem
whole
genom
analysi
focus
na
sequenc
confirm
pattern
oseltamivir
resist
virus
show
virus
oseltamivir
sensit
resist
oseltamivir
contain
least
one
abovement
na
mutat
addit
predomin
tabl
lower
preval
oseltamivirresist
human
virus
appar
due
absenc
permiss
secondari
mutat
k
confer
robust
fit
virus
although
preval
k
decreas
temporarili
second
half
permiss
secondari
mutat
becom
predomin
addit
file
tabl
observ
suggest
greater
divers
na
mutat
confer
oseltamivir
resist
among
current
human
influenza
virus
result
higher
mutat
frequenc
due
lowfidel
rdrp
facilit
adapt
mutat
na
select
pressur
nai
oseltamivir
summari
found
natur
occur
mutat
influenza
virus
affect
replic
fidel
virul
adapt
result
suggest
presenc
mammalian
signatur
human
virus
reduc
rdrp
fidel
confer
growth
advantag
increas
probabl
adapt
mutat
rel
human
virus
bear
avian
signatur
result
also
suggest
canon
lowfidel
rdrp
increas
adapt
fit
virus
human
host
biolog
mechan
underli
replac
virus
rel
higher
fidel
rdrp
follow
emerg
therefor
continu
surveil
natur
occur
variant
among
other
warrant
assess
potenti
impact
chang
rdrp
fidel
adapt
epidemiolog
fit
human
influenza
virus
addit
file
tabl
epidemiolog
studi
oseltamivir
resist
mutat
na
gene
human
influenza
virus
use
sequenc
deposit
ncbi
influenza
databas
figur
evolut
analysi
influenza
show
serinetoglycin
point
mutat
occur
figur
schemat
diagram
influenza
artifici
genom
contain
dualluciferas
measur
rdrp
fidel
influenza
viru
replic
influenza
virusinfect
hek
cell
poli
start
transcrib
negativestrand
viral
rna
initi
selfrepl
report
purpos
report
normal
total
replic
capabl
first
rluc
activ
also
evalu
mutat
potenti
result
express
downstream
fluc
activ
rluc
activ
reflect
influenza
replic
level
fluc
activ
measur
event
rdrp
repair
engin
stop
codon
rluc
fluc
report
replicationdriven
fluc
activ
thu
repres
mutat
potenti
viru
calcul
cmi
base
ratio
flucrluc
serv
arbitrari
measur
number
mutat
event
occur
viru
replic
andor
viral
transcript
figur
epidemiolog
survey
residu
substitut
influenza
virus
residu
virus
residu
virus
examin
use
data
deriv
influenza
viru
databas
genbank
deposit
prior
octob
figur
effect
mutat
influenza
viru
replic
capabl
adapt
cell
treat
oseltamivir
docx
kb
